Curaleaf Holdings, Inc. (CURA.TO)

CAD 1.22

(2.1%)

Operating Income Summary of Curaleaf Holdings, Inc.

  • Curaleaf Holdings, Inc.'s latest annual operating income in 2023 was 42.88 Million USD , down -31.59% from previous year.
  • Curaleaf Holdings, Inc.'s latest quarterly operating income in 2024 Q2 was 7.54 Million USD , down -40.32% from previous quarter.
  • Curaleaf Holdings, Inc. reported an annual operating income of 84.6 Million USD in 2022, up 15.21% from previous year.
  • Curaleaf Holdings, Inc. reported an annual operating income of 73.43 Million USD in 2021, up 135.98% from previous year.
  • Curaleaf Holdings, Inc. reported a quarterly operating income of 17.12 Million USD for 2024 Q1, down -11.9% from previous quarter.
  • Curaleaf Holdings, Inc. reported a quarterly operating income of 20.4 Million USD for 2023 Q3, up 314.53% from previous quarter.

Annual Operating Income Chart of Curaleaf Holdings, Inc. (2023 - 2016)

Historical Annual Operating Income of Curaleaf Holdings, Inc. (2023 - 2016)

Year Operating Income Operating Income Growth
2023 42.88 Million USD -31.59%
2022 84.6 Million USD 15.21%
2021 73.43 Million USD 135.98%
2020 -204.1 Million USD -22.61%
2019 -166.46 Million CAD -342.93%
2018 -37.58 Million CAD -171.39%
2017 -13.84 Million CAD -8617.95%
2016 -158.85 Thousand CAD 0.0%

Peer Operating Income Comparison of Curaleaf Holdings, Inc.

Name Operating Income Operating Income Difference
Aurora Cannabis Inc. -46.45 Million CAD 192.315%
Avicanna Inc. -7.93 Million CAD 640.564%
Avant Brands Inc. -1.45 Million CAD 3055.41%
Cardiol Therapeutics Inc. -29.78 Million CAD 243.973%
Crescita Therapeutics Inc. -1.95 Million CAD 2292.382%
Knight Therapeutics Inc. -2.89 Million CAD 1583.841%
MediPharm Labs Corp. -18.25 Million CAD 334.95%
OrganiGram Holdings Inc. -242.73 Million CAD 117.666%
Canopy Growth Corporation -228.71 Million CAD 118.75%
Willow Biosciences Inc. -13.18 Million CAD 425.315%
Auxly Cannabis Group Inc. -19 Million CAD 325.641%